Friday 15 August 2025 | 15:20-15:45 

Format: Presentation

Stream: Safety

Part 1: When Immediate Risks Need Immediate Solutions. Safety Action Team – Sustainable Oversight of Immediate Risk and Proactive Improvements in Care

Following an increase in the number of serious adverse events our facility implemented a task force, and the creation of an immediate risk mitigation team (Safety Action Team (SAT)) that has consistently met twice weekly for more than 18 months. We will discuss how this team consisting of a collaborative group of senior clinicians and both senior executive and hospital management has been able to transform and sustain a patient safety culture that has both reduced the number and type of serious adverse events and provided an ongoing forum for the discussion of shared clinical concerns for facility wide immediate risk mitigation.

Helen Crowther Blacktown Mt Druitt Hospital; Australia

Part 2: Building safety and reliability in Regenerative Medicine

Regenerative medicine is a new treatment that has been highly anticipated, and private clinics and regenerative medicine-related products are gaining popularity in Japan. However, as its popularity grows, concerns about safety and reliability are also increasing, and there are cases where the quality of medical care has declined. For this reason, the safety and reliability of regenerative medicine have emerged as important issues. In Japan, the “Act on Comprehensive Promotion of Measures to Ensure that the Public Can Receive Regenerative Medicine Promptly and Safely (Regenerative Medicine Promotion Act)” was enacted in 2013 to promote regenerative medicine through policy.

Based on the many achievements obtained through the Special Certified Regenerative Medicine Committee, where I serve as a technical evaluation committee member, I will consider the establishment of safety and reliability of regenerative medicine and regenerative medicine-related products in Japan.

Hisashi Takeuchi Japan Society of Advanced Medical Sciences; Japan

Part 3: Research-embedded co-design as an approach to developing more sustainable medication safety interventions

In this session we will discuss how co-design, as an established collaborative method where healthcare staff and patients are involved, is an effective approach to developing more sustainable medication safety interventions. Delegates will gain a richer understanding of co-design and specifically, experience-based co-design (EBCD), and how a key benefit is ensuring that improvements developed are grounded in users lived experiences. This approach leads to interventions which are more sustainable in the current healthcare climate, thus are more likely to be implemented in clinical practice.

During the session, we will present two multi-stage intervention development research studies, MEDS-MADE and RESI-Med. Both examples started with literature review and qualitative research underpinned by a theoretical framework, then moved on to intervention development via co-design.

The session will also explore what works, what doesn’t work so well, why co-design with patients and healthcare staff is fundamental to developing interventions for clinical practice, and hear delegates co-design experiences.

Hadeel Mohamed University of Bradford; United Kingdom